Quick Answer
ENANTA PHARMACEUTICALS INC reported Total Revenue of $65.32 million for fiscal year 2025.
ENANTA PHARMACEUTICALS INC Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $65.32M | -3.4% |
| 2024 | $67.64M | -14.6% |
| 2023 | $79.20M | -8.1% |
| 2022 | $86.16M | -11.2% |
| 2021 | $97.07M | -20.7% |
| 2020 | $122.47M | -40.3% |
| 2019 | $205.20M | -0.7% |
| 2018 | $206.62M | +101.0% |
| 2017 | $102.81M | +16.5% |
| 2016 | $88.27M | -45.1% |
| 2015 | $160.88M | +237.0% |
| 2014 | $47.74M | +48.9% |
| 2013 | $32.05M | -23.1% |
| 2012 | $41.71M | -0.4% |
| 2011 | $41.88M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $18.61M | +9.8% | +1.6% |
| June 30, 2025 | $18.31M | +1.9% | +22.7% |
| March 31, 2025 | $14.93M | -12.5% | -12.0% |
| December 31, 2024 | $16.96M | -5.8% | -5.6% |
| June 30, 2024 | $17.97M | -4.9% | +5.4% |
| March 31, 2024 | $17.05M | -4.2% | -5.3% |
| December 31, 2023 | $18.00M | -23.7% | -4.7% |
| June 30, 2023 | $18.89M | -3.0% | +6.2% |
- ENANTA PHARMACEUTICALS INC showed a decrease of -3.4% in Total Revenue compared to the prior fiscal year.
- Over the 2011–2025 period, ENANTA PHARMACEUTICALS INC’s total revenue has grown by 56.0% (from $41.88 million to $65.32 million).
- The most recent figure is from ENANTA PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 19, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: